In the latter study, Badgley et al. developed a seven-allele genetically engineered mouse model of pancreatic cancer in which tumors could be initiated using the Flp-Frt recombination system and whole body Slc7a11 deletion could be initiated by tamoxifen administration. Here, SLC7A11 is linked to pancreatic neoplasm.